Note on sources
All site content, whether news or articles, shall be accompanied by the indication of single source or multiple sources: in fact the article is often written by drawing on several sources. All sources listed can be verified directly by the reader; they are provided of web site whose address is listed on the page of links. Very often these are Associations of patients and their families, well-recognized and accredited in their countries of origin, having its own Scientific Committee.
In the case of scientific publications, it is always shown the publishing journal and the abstract; the original article is often present.
The translations are made by the site manager from English into Italian and vice versa and from French to Italian.
This site is aimed at everyone involved in the fight against spinal muscular atrophy, whether patients and their families, physicians, health professionals or students of the area. The information in this site serves to enhance, not replace, the doctor-patient relationship.
Note on site manager
Note on sources
LAST UPDATE: July 25, 2010
No advertising on this site!
CAUTION Medical contents on the site are purely for guidance and information and cannot replace in any case the medical advice.
All contents provided by the site are written exclusively by professionals in the medical-scientific area, unless an explicit statement does not specify otherwise.- - Researchers demonstrate efficacy of antisense therapy for spinal muscular atrophy
- - Gene therapy rescues mice with SMA
- - Isis Pharmaceuticals towards an antisense drug
- - New finding clarifies the cause of SMA
- - Trans-splicing and gene therapy
- - Strengthening the junctions
- - New European funding for SMA research
- - New publications on SMA
This site complies with
the HONcode standard
for trustworthy health
information: verify here.
If you need Adobe PDF reader
download it from here:
